Status:
UNKNOWN
Effect of the Duration of Pre-oxygenation on Apnea Tolerance in Obese Patients During the Induction of General Anesthesia
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Anesthesia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The occurrence of arterial oxygen desaturation (hypoxemia) during the induction of general anesthesia remains one of the main causes of complications and mortality in anesthesia. In a healthy patient ...
Eligibility Criteria
Inclusion
- Patient aged ≥ 18 years
- Patient to have general anesthesia
- Patient affiliated to a health insurance plan
- French-speaking patient
- Patient who has given free, informed and written consent
Exclusion
- Patient with a BMI between 25 and 30 kg / m2
- Patient with a BMI\> 40 kg / m2
- Patient whose O2 stock is insufficient, without this being linked to obesity
- Patient with severe respiratory pathology (COPD stage 3 or 4, severe asthma)
- Patient with active smoking
- Patient with a history of lobectomy or pneumonectomy
- Patient coming for emergency surgery
- Patient with a known allergy to rocuronium or sufentanil or propofol
- Pregnant or breastfeeding women
- Patient under guardianship or curatorship
- Patient deprived of liberty
Key Trial Info
Start Date :
January 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04699435
Start Date
January 13 2021
End Date
December 30 2024
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, Groupe Hospitalier Paris Saint-Joseph, France, 75014